Clover Biopharmaceuticals Launches Phase 2 Trial for Novel Combination Vaccine Against RSV, hMPV, and PIV3 Clover Biopharmaceuticals has initiated a Phase 2 clinical trial for its innovative combination vaccine targeting RSV, hMPV, and PIV3, promising a significant leap in respiratory disease prevention.

Clover Biopharmaceuticals Launches Phase 2 Trial for Novel Combination Vaccine Against RSV, hMPV, and PIV3 #Shanghai #Australia #RSV_Vaccine #Phase_2_Trial #Clover_Biotech

AMI Pharm's AYP-101 Shows Promising Results in Phase 2 Trial for Non-Surgical Fat Reduction AMI Pharm's AYP-101 demonstrates significant effectiveness in a Phase 2 trial, heralding a new era in non-surgical fat reduction treatments, particularly for submental fat.

AMI Pharm's AYP-101 Shows Promising Results in Phase 2 Trial for Non-Surgical Fat Reduction #South_Korea #Seoul #AMI_Pharm #AYP-101 #Phase_2_Trial